malondialdehyde has been researched along with ocotillol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, F; Han, B; Yu, C; Yu, X; Zhu, M | 1 |
| Fu, F; Fu, X; Kong, L; Li, G; Tang, M; Wang, H; Zhang, J; Zhou, X | 1 |
2 other study(ies) available for malondialdehyde and ocotillol
| Article | Year |
|---|---|
Cardioprotective effect of ocotillol, a derivate of pseudoginsenoside F11, on myocardial injury induced by isoproterenol in rats.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Ginsenosides; Injections, Subcutaneous; Isoproterenol; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardium; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2007 |
Protective effect of ocotillol against doxorubicin‑induced acute and chronic cardiac injury.
Topics: Acute Disease; Animals; Cardiomyopathies; Chronic Disease; Creatine Kinase, MB Form; Disease Models, Animal; Doxorubicin; Ginsenosides; Glutathione; Kaplan-Meier Estimate; Leukocyte Count; Leukocytes; Male; Malondialdehyde; Mice; Myocardium; Protective Agents | 2014 |